Asthma Economic Costs in Adult Asthmatic XXXX in Tehran, Iran.

@entity748 @entity1 @entity1178 @entity565
BACKGROUND: High prevalence and increasing rate of @entity748 @entity1 around the word witnesses the high burden of @entity565 . We have limited data on @entity565 burden and economic costs in Iran. This study aimed to find direct and indirect economic costs of @entity565 and their association with some background factors in one of the referral tertiary centers for adult @entity1 with @entity565 . METHODS: We surveyed @entity565 related economic costs of 197 adult @entity1 who referred to Milad Hospital, Tehran, Iran from @entity1178 2007 to January 2010. The @entity1 were followed up for a period of one-year   1 month and @entity565 related costs and its control status were registered. RESULTS: @entity1 were consisted of 125 (64.1%) females and 70 (35.9%) males. Total cost of @entity565 was 590.22   32.18 USD for one @entity1 per one year, the cost of drug, paraclinic, doctor visit, hospitalization, emergency, transportation, and absent days were 327.02, 4.76, 35.44, 3.82, 0.26, 113.03, 105.89 USD respectively. @entity1 showed a significant elevation in their total (P=0.009) and drug costs (P=0.028). In addition, we found significant differences between total @entity565 costs and @entity565 control status (P=0.002). CONCLUSIONS: According to the high proportion of @entity565 , related cost compare to Total Income of an Iranian family, the necessity of public coverage of health assurance is quite clear. We suggest that improving @entity565 management and accessibility to specialized treatment centers can result in decreasing @entity565 medication and transportation costs as major direct and indirect @entity565 related costs.
